Gamma Investing LLC Nuvalent, Inc. Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 194 shares of NUVL stock, worth $16,623. This represents 0.0% of its overall portfolio holdings.
Number of Shares
194
Previous 141
37.59%
Holding current value
$16,623
Previous $10 Million
48.02%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NUVL
# of Institutions
216Shares Held
60.9MCall Options Held
319KPut Options Held
211K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.54 Billion32.3% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$452 Million19.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$380 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$259 Million0.01% of portfolio
-
Commodore Capital LP New York, NY1.86MShares$159 Million12.88% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.68B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...